5.79
Lexeo Therapeutics Inc (LXEO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
|
|
29.46%
21.65
|
30.69 | 33.80 | 27.38 | 31.54 |
| Depreciation and Amortization |
17.74%
0.073
|
0.062 | 0.06 | 0.075 | 0.083 |
| Operating Income/Loss |
29.46%
-21.65
|
-30.69 | -33.80 | -27.38 | -31.54 |
| Nonoperating Income/Loss |
70.23%
1.365
|
4.585 | 1.149 | 1.458 | 2.054 |
| Income/Loss From Continuing Operations Before Tax |
22.30%
-20.28
|
-26.10 | -32.66 | -25.92 | -29.49 |
| Income/Loss From Continuing Operations After Tax |
22.30%
-20.28
|
-26.10 | -32.66 | -25.92 | -29.49 |
|
|
22.30%
-20.28
|
-26.10 | -32.66 | -25.92 | -29.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
39.95%
60.98
|
43.57 | 33.11 | 0.4327 | 33.06 |
| Diluted Average Shares |
39.95%
60.98
|
43.57 | 33.11 | 0.4327 | 33.06 |
| Basic Earnings Per Share |
45.00%
-0.33
|
-0.60 | -0.99 | -0.78 | -0.89 |
| Diluted Earnings Per Share |
45.00%
-0.33
|
-0.60 | -0.99 | -0.78 | -0.89 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):